US Asset Strategy, Obesity and Related Conditions, Director

Amgen•Thousand Oaks, CA
•$184,336 - $249,396

About The Position

The Director, US Asset Strategy leads US commercial strategy for future indications across Amgen’s obesity and related conditions portfolio, initially focusing on the next anticipated indication. The role translates Global strategy into actionable US plans using knowledge of the US market and practical commercialization experience, and works with Global Marketing and US cross-functional partners from early commercial planning through approval and launch readiness. The Director identifies market opportunities, develops indication-specific strategies, and helps the established commercial organization prepare for execution. As the portfolio evolves, the role will support additional indications, coordinate plans with teams supporting the approved indication, and lead and develop a direct report. The position balances strategic planning with hands-on execution and requires collaboration across US and Global organizations.

Requirements

  • Doctorate degree and 4 years of Marketing experience, or a Master’s degree and 7 years of Marketing experience, or a Bachelor’s degree and 9 years of Marketing experience.

Nice To Haves

  • Significant US pharmaceutical or biotechnology commercialization experience, with demonstrated success translating Global asset or brand strategy into effective US plans.
  • Experience preparing new products or indications for launch, including planning through regulatory approval and commercial execution.
  • Strong understanding of Global and US commercial organizations, US market dynamics, customer needs, and commercialization requirements.
  • Ability to interpret clinical evidence, treatment paradigms, competitive intelligence, and research to inform US commercial strategy.
  • Experience developing US indication strategies, including market assessment, customer segmentation, positioning, and launch planning.
  • Strong understanding of US healthcare delivery, market access, HCP engagement, and patient marketing.
  • Ability to lead and develop people and drive accountability for results.
  • Success influencing senior leaders and coordinating cross-functional teams in highly matrixed organizations.
  • Excellent executive communication and presentation skills, including ability to simplify complex scientific and commercial information.
  • Track record of delivering results in fast-paced, high-visibility environments while balancing strategy with detailed execution.

Responsibilities

  • Develop and lead US commercial strategy for future indications, translating Global strategy into plans that reflect US market dynamics, customer needs, and commercial priorities.
  • Assess US treatment pathways, patient populations, HCP segments, competitive dynamics, and unmet needs to inform indication positioning and priorities.
  • Partner with Global Marketing to understand evidence, strategic assumptions, and development milestones and translate their implications for US commercialization.
  • Collaborate with Insights & Analytics to shape US market research, interpret customer insights, and refine indication strategy.
  • Identify US opportunities and challenges and provide recommendations to commercial leadership.
  • Lead US commercial planning for future indications from early preparation through regulatory milestones, approval, and launch readiness.
  • Translate indication strategy into US commercialization requirements, milestones, and functional priorities.
  • Partner with Medical Affairs, Market Access, HCP Marketing, Consumer Marketing, Sales, Analytics, Regulatory, Corporate Affairs, and Operations to integrate indication needs into established plans.
  • Anticipate the US commercial implications of clinical data, regulatory decisions, competitor developments, and changing market conditions.
  • Identify gaps, dependencies, and execution risks and work with functional owners and Launch Integration to address them.
  • Support development of indication-specific US readiness criteria and performance measures with the core launch team.
  • Assess how additional indications may affect US customer segments, treatment pathways, targeting, promotional priorities, and commercial capabilities.
  • Partner with established US brand teams to leverage existing strategies, customer engagement platforms, and infrastructure where appropriate.
  • Ensure future indication plans complement the approved indication and support a coordinated experience for HCPs and patients.
  • Serve as the primary US commercial strategy contact for future indications, connecting Global planning with US execution requirements.
  • Lead, coach, and develop a direct report, establishing priorities, accountability, and standards for delivery.
  • Build relationships across US and Global leadership teams and influence decisions without direct authority over partner functions.
  • Synthesize clinical, competitive, customer, and commercial information into concise recommendations and leadership decision materials.
  • Balance strategic thinking with hands-on execution and foster collaboration, ownership, and results.

Benefits

  • Comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions.
  • Group medical, dental, and vision coverage.
  • Life and disability insurance.
  • Flexible spending accounts.
  • Discretionary annual bonus program, or a sales-based incentive plan for field sales representatives.
  • Stock-based long-term incentives.
  • Award-winning time-off plans.
  • Flexible work models where possible.
  • Career development opportunities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service